ATLANTA, Oct. 25, 2006 (PRIMEZONE) -- OTC Stock Review announces that it has initiated coverage of Liska Biometry (OTCBB:LSKA). Liska Biometry, headquartered in Dover, New Hampshire, develops revolutionary fingerprint biometric solutions enabling fast individual authentication, precise identification searches, as well as cross-platform data interoperability. Its innovative, scalable technology generates a unique, short, repeatable numerical identifier from one's fingerprint.
This short number becomes a precise and universal biometric identifier easily embedded in travel documents, such as visas and passports, credit cards, driver's licenses and a host of other personal credentials.
LSKA product offerings address Homeland Security concerns regarding privacy and data integrity. From consular services to terrorist watch lists, its innovative technology allows for seamless, integrated identification searches across disparate databases at all levels of government and law enforcement.
Increased public awareness about the need for more pervasive security protocols is one of the biggest drivers of the biometrics industry as a whole. However, several key factors serve to hinder rapid adoption of biometric technology: rapid identification and verification of subjects, data interchange and interoperability, as well as citizen's concerns with privacy, accuracy and data integrity. Liska's software solution addresses all of these concerns.
The complete report is available at http://www.otcstockreview.com/Files/LSKA/LSKA_Review.pdf.
Additionally, more information on Liska Biometry is available at http://www.otcstockreview.com/lska.htm or at http://www.liskabiometry.com.
OTC Stock Review provides a comprehensive review of financial market coverage, specifically the microcap market, by newsletters, mutual funds, brokerage firm and independent research firms. OTC Stock Review defines the microcap segment of the equity market as companies with less than $250 million in market capitalization. Members receive regular emails of stock opinions and market coverage, including both global and domestic. Please visit http://www.otcstockreview.com.
NOTE: The purpose of this release is to introduce the reader to OTCStockReview.com and Liska Biometry. OTC Stock Review is not a Registered Investment Advisor or a Broker/Dealer. Information and opinions presented in this release are solely for informative purposes and not intended, nor should they be construed as, investment advice. This document contains information obtained from public sources about Liska Biometry, but does not contain all the relevant material information necessary to evaluate the company. This release is not to be considered an offer to buy, sell, hold, and/or otherwise trade in the securities of Liska Biometry, as profiled. OTC Stock Review has been compensated $15,000 to perform investor relations services for Liska Biometry. Officers, directors, and employees of OTC Stock Review, may hold a long or short equity position of a profiled Company and may trade in these securities for their own accounts. Carefully review profiled companies with your investment advisor, stockbroker, or other such professional. OTC Stock Review is not liable for any investment decisions by its readers or their advisors. Any analysis contained herein does not purport to be a complete analysis of the profiled companies. Readers are encouraged to obtain copies of the profiled Company's periodic reports filed with United States Securities and Exchange Commission, which are generally available at http://www.sec.gov. You can view our complete disclaimer at http://www.otcstockreview.com/disclaimer.htm